Oncothyreon Inc. (ONTY) has 14 open-market insider trades by 11 insiders since 2008. The most active filer is Biotechnology VALUE FUND L P.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| BVF Inc/il | 10% | — | 1 | $688K | 2014-12-17 |
| Biotechnology VALUE FUND L P | — | — | 2 | $617K | 2013-11-01 |
| Biotechnology VALUE FUND II L.P. | — | — | 1 | $589K | 2013-08-01 |
| Jay Venkatesan | EVP and General Manager | — | 1 | $500K | 2014-09-23 |
| Mark N. Lampert | 10% | — | 1 | $426K | 2013-08-08 |
| Capital Management Lp Ayer | 10% | — | 1 | $253K | 2011-06-23 |
| Daniel K. Spiegelman | Dir | — | 2 | $63K | 2015-06-13 |
| Shashi K. Karan | Controller | — | 2 | $43K | 2010-09-28 |
| Diana Hausman | Chief Medical Officer | — | 1 | $27K | 2015-06-01 |
| Richard L. Jackson | Dir | — | 1 | $13K | 2015-06-13 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Diana Hausman | Chief Medical Officer | Buy | $27K | 2015-06-01 |
| Daniel K. Spiegelman | Director | Buy | $32K | 2015-03-25 |
| BVF Inc/il | 10% | Buy | $688K | 2014-12-15 |
| Jay Venkatesan | EVP and General Manager | Buy | $500K | 2014-09-23 |
| Biotechnology VALUE FUND L P | — | Buy | $230K | 2013-11-01 |
| Mark N. Lampert | 10% | Buy | $426K |
Companies that share insiders with ONTY, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2013-08-08 |
| Biotechnology VALUE FUND II L.P. | — | Buy | $589K | 2013-07-31 |
| Biotechnology VALUE FUND L P | — | Buy | $387K | 2013-06-05 |
| Daniel K. Spiegelman | Director | Sell | $31K | 2013-02-20 |
| Capital Management Lp Ayer | 10% | Sell | $253K | 2011-06-23 |
| Shashi K. Karan | Controller | Buy | $17K | 2010-09-28 |
| Shashi K. Karan | Controller | Buy | $25K | 2009-08-18 |
| Richard L. Jackson | Director | Buy | $13K | 2008-02-12 |
| Edward A. Taylor | CFO & VP Fin Admin +1 | Buy | $8K | 2008-01-18 |